Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NEMLUVIO safely and effectively. See full prescribing information for NEMLUVIO. NEMLUVIO® (nemolizumab-ilto) for injection, for subcutaneous use Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
NEMLUVIO is indicated for the treatment of adults with prurigo nodularis. NEMLUVIO is indicated for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not adequately controlled with topical prescription therapies.
- generic_name
- nemolizumab-ilto
- product_names
- nemolizumab-ilto
- ndc
- 0299-6220, 0299-6220-15, 0299-6220-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en